U.S. Bancorp (NYSE:USB) Shares Sold by Lincluden Management Ltd.

Lincluden Management Ltd. lessened its stake in U.S. Bancorp (NYSE:USB) by 0.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 153,657 shares of the financial services provider’s stock after selling 787 shares during the quarter. U.S. Bancorp makes up approximately 0.9% of Lincluden Management Ltd.’s holdings, making the stock its 25th biggest holding. Lincluden Management Ltd.’s holdings in U.S. Bancorp were worth $7,349,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of USB. Winch Advisory Services LLC boosted its stake in U.S. Bancorp by 1,088.9% in the fourth quarter. Winch Advisory Services LLC now owns 535 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 490 shares during the period. FPC Investment Advisory Inc. acquired a new position in U.S. Bancorp during the 4th quarter valued at approximately $28,000. Frazier Financial Advisors LLC grew its stake in U.S. Bancorp by 222.7% during the 3rd quarter. Frazier Financial Advisors LLC now owns 639 shares of the financial services provider’s stock worth $29,000 after buying an additional 441 shares during the last quarter. Global Wealth Strategies & Associates increased its position in U.S. Bancorp by 70.8% in the fourth quarter. Global Wealth Strategies & Associates now owns 603 shares of the financial services provider’s stock worth $29,000 after buying an additional 250 shares during the period. Finally, Stonebridge Financial Group LLC bought a new stake in U.S. Bancorp in the fourth quarter valued at $30,000. Institutional investors own 77.60% of the company’s stock.

Wall Street Analysts Forecast Growth

USB has been the subject of several recent research reports. Barclays upped their price target on shares of U.S. Bancorp from $57.00 to $61.00 and gave the stock an “overweight” rating in a research report on Monday, January 6th. Morgan Stanley decreased their target price on shares of U.S. Bancorp from $60.00 to $59.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Truist Financial began coverage on U.S. Bancorp in a report on Tuesday, January 7th. They set a “hold” rating and a $54.00 price target on the stock. Raymond James raised U.S. Bancorp from a “market perform” rating to an “outperform” rating and set a $57.00 price objective for the company in a report on Thursday, December 19th. Finally, Compass Point raised their target price on U.S. Bancorp from $49.00 to $60.00 and gave the company a “buy” rating in a research report on Tuesday, December 10th. Ten equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $54.21.

Insider Activity at U.S. Bancorp

In other news, CEO Andrew Cecere sold 102,044 shares of the business’s stock in a transaction that occurred on Tuesday, February 4th. The shares were sold at an average price of $47.25, for a total transaction of $4,821,579.00. Following the sale, the chief executive officer now owns 1,230,316 shares in the company, valued at $58,132,431. The trade was a 7.66 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jodi L. Richard sold 30,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 6th. The stock was sold at an average price of $47.59, for a total transaction of $1,427,700.00. Following the completion of the transaction, the insider now directly owns 99,790 shares of the company’s stock, valued at $4,749,006.10. This represents a 23.11 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 219,812 shares of company stock worth $10,385,665 in the last quarter. 0.23% of the stock is owned by company insiders.

U.S. Bancorp Stock Down 0.7 %

NYSE USB opened at $45.57 on Tuesday. U.S. Bancorp has a 12 month low of $37.81 and a 12 month high of $53.98. The company has a market capitalization of $71.08 billion, a P/E ratio of 12.02, a PEG ratio of 1.73 and a beta of 1.04. The company’s 50 day simple moving average is $48.08 and its 200 day simple moving average is $47.76. The company has a debt-to-equity ratio of 1.11, a current ratio of 0.81 and a quick ratio of 0.80.

U.S. Bancorp (NYSE:USB) last posted its quarterly earnings results on Thursday, January 16th. The financial services provider reported $1.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.06 by $0.01. The company had revenue of $7.01 billion for the quarter, compared to analysts’ expectations of $7 billion. U.S. Bancorp had a return on equity of 12.94% and a net margin of 14.75%. The firm’s revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.99 earnings per share. Equities research analysts expect that U.S. Bancorp will post 4.38 earnings per share for the current fiscal year.

U.S. Bancorp Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Investors of record on Tuesday, December 31st were given a $0.50 dividend. The ex-dividend date was Tuesday, December 31st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 4.39%. U.S. Bancorp’s dividend payout ratio (DPR) is 52.77%.

U.S. Bancorp Profile

U.S. Bancorp, a financial services holding company, provides various financial services to individuals, businesses, institutional organizations, governmental entities, and other financial institutions in the United States. It operates through Wealth, Corporate, Commercial and Institutional Banking; Consumer and Business Banking; Payment Services; and Treasury and Corporate Support segments.